sensitivity antitubulin chemotherapeutics regulated mcl1 fbw7 
microtubules pivotal roles fundamental cellular processes targets antitubulin chemotherapeutics1 microtubule-targeted agents taxol vincristine prescribed widely various malignancies including ovarian breast adenocarcinomas non-small-cell lung cancer leukaemias lymphomas1 agents arrest cells mitosis subsequently induce cell death poorly defined mechanisms2 strategies resistant tumour cells use evade death induced antitubulin agents also unclear2 show pro-survival protein mcl1 ref crucial regulator apoptosis triggered antitubulin chemotherapeutics mitotic arrest mcl1 protein levels decline markedly post-translational mechanism potentiating cell death phosphorylation mcl1 directs interaction tumour-suppressor protein fbw7 substrate-binding component ubiquitin ligase complex polyubiquitylation mcl1 targets proteasomal degradation degradation mcl1 blocked patient-derived tumour cells lacked fbw7 loss-of-function mutations fbw7 conferring resistance antitubulin agents promoting chemotherapeutic-induced polyploidy additionally primary tumour samples enriched fbw7 inactivation elevated mcl1 levels underscoring prominent roles proteins oncogenesis findings suggest profiling fbw7 mcl1 status tumours terms protein levels messenger rna levels genetic status useful predict response patients antitubulin chemotherapeutics 
